Scientists have identified a key gene - eIF4G1 - that shows grade and stage specific upregulation in prostate cancer and is overexpressed and/or amplified in the majority of cases of CRPC.
The School of Graduate Studies helps to train future scientists and our Centers further elevate our institution's research portfolio. The Office of Research helps support these endeavors and is comprised of the Clinical Trials Office, the Office of Sponsored Programs and Technology Transfer, Human Research Protections Program (HRPP) and the Institutional Review Board (IRB).
RESEARCH ON THE RISE
Federal, State & Private Grants were up by 47% in 2018 over 2017.
353 Active Clinical Studies on Campus.
5 Start-up Companies created to license and commercialize LSUHS technologies.
9 USPTO Patent Notices of allowance for LSUHS technologies.
34 new Pharma Studies sponsored by a pharmaceutical company.
Total Grant Funding for 2018 was $14,814,174.
Office of Research
John W. Maloy, JD
Assistant Vice Chancellor for Research Management
Sha Williams, MBA
(318) 675-4175 Fax
Suzie Golas, Coordinator
Danielle Hartman, Coordinator
Drs. Kevil and Orr interviewed by American Heart Association News and featured in Washington Post article.
Although frequently overshadowed by the opioid epidemic, surging methamphetamine use nationally and around the world has fueled a chilling crisis of its own, according to a new report;
A study performed by LSUHS Orthopaedic Surgery faculty, residents and medical students was recently published in and featured on the cover of the Orthopaedic Research Society's Journal of Orthopaedic Research.
The grant entitled, “The role of alpha-synuclein in Snx3-retromer mediated recycling of membrane proteins.” provides Dr. Witt with $100,000 per year each year for three years.
The LSU Health Shreveport Department of Molecular & Cellular Physiology and Aphios Corporation have obtained United States Patent No. 9,994,585 entitled “Transplantation Therapies,” for marine pharmaceutical ‘Bryostatin-1,’ which will be used as an additive to organ transport and storage solutions.
Congratulations to Principal Investigator Dr. David Gross for being awarded an R15 AREA grant entitled, “Chromosomal Conformation and Nuclear Organization of Heat Shock Protein Genes.” The grant provides Dr. Gross with $100,000 per year each year for three years.
Almost all deaths from prostate cancer are a result of emergence of CRPC. Scientists from our Department of Biochemistry and Molecular Biology and Feist Weiller Cancer Center have identified a key gene - eIF4G1- that is overexpressed in the majority of cases of CRPC, allowing these cancer cells to rapidly respond to androgen deprivation therapies.
The Science & Medicine Academic Research Training Program provides academically advanced high school seniors who are interested in careers related to medicine, scientific research, and biomedical engineering opportunities to engage in intensive research with medical clinicians, researchers, and academic staff.